Anthropic has established a wet lab in the San Francisco Bay Area to advance its AI drug discovery program, moving beyond computer-based research into physical biology experiments. The startup aims to develop treatments for rare diseases neglected by pharmaceutical companies, with CEO Dario Amodei personally motivated by his father's death from disease. Anthropic plans to use AI to automate lab work through robotic units while maintaining human oversight for safety.